Last reviewed · How we verify

NCT03916445

Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases

Completed Last updated 4 June 2020
What this trial tests

trial testing Connor Davidson Resilience Scale (CD-RISC 10) in Gynecologic Disease in 132 participants. Completed in 26 April 2019.

Timeline
28 March 2019
Primary endpoint
26 April 2019
26 April 2019

Quick facts

Lead sponsorUniversity Hospital, Basel, Switzerland
StatusCompleted
Study typeOBSERVATIONAL
Enrollment132
Start date28 March 2019
Primary completion26 April 2019
Estimated completion26 April 2019
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Basel, Switzerland

Who can join

18 and older, female only, with Gynecologic Disease or Gynecologic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The intended pilot project aims at evaluating the feasibility and acceptability of questionnaires about resilience and quality of life in two different patient groups (either with a gynaecological carcinoma ora chronic gynaecological disease). The results provided by this pilot study will build the basis of an upcoming, larger project including these questionnaires and the main objective of assessing resilience. More precisely, the study aims at answering the following questions. How is the overall resilience and quality of life in the target population at one assessment point? Are the instruments used in this pilot feasible for the target population when assessing resilience and quality of life?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gynecologic Disease

Currently open trials in the same condition.

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03916445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing